(AGENPARL) – SILVER SPRING lun 27 giugno 2022 On June 24, 2022, the Food and Drug Administration approved lisocabtagene maraleucel (Breyanzi,…
Browsing: patients
(AGENPARL) – SILVER SPRING lun 27 giugno 2022 Tafinlar (dabrafenib) In combination with trametinib for adult and pediatric patients 6 years…
(AGENPARL) – WASHINGTON lun 27 giugno 2022 Enhancing Oncology Model Aims to Improve Patient-Centered Care, Lower Health Care Costs, and…
(AGENPARL) – LONDON sab 25 giugno 2022 MHRA to reform medical devices regulation to improve patient health and encourage innovation…
(AGENPARL) – SILVER SPRING ven 24 giugno 2022 FDA is working to provide guidance to states and compounders on issues associated…
(AGENPARL) – SILVER SPRING gio 23 giugno 2022 FDA grants accelerated approval to dabrafenib in combination with trametinib for unresectable or…
(AGENPARL) – SILVER SPRING gio 23 giugno 2022 On June 22, 2022, the Food and Drug Administration granted accelerated approval to…
(AGENPARL) – SILVER SPRING gio 23 giugno 2022 On May 27, 2022, the Food and Drug Administration granted accelerated approval to…
(AGENPARL) – NEW HAVEN, CONNECTICUT (USA) mer 22 giugno 2022 A type of cancer treatment known as CAR T therapy has…
(AGENPARL) – NEW HAVEN, CONNECTICUT (USA) mer 22 giugno 2022 Yale School of Nursing (YSN) saluted preceptors in every specialty and…